LAS VEGAS -- (BUSINESS WIRE) -- Medican Enterprises, Inc. (OTCBB: MDCN) a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce its joint venture partner International Herbs Medical Marijuana Ltd (“IHMML”) received conditional zoning approval from the Corporation of Delta (often referred to as the City of Delta, a suburb of Vancouver, British Columbia) . As previously announced in our press release dated March 18, 2014, we are working together with IHMML on several projects in Canada, including the project in Delta. IHMML was founded by the owners of International Herbs Ltd (“IHL”), Western Canada’s largest fresh herb grower, importer, distributor and a leading specialty herbal produce grower in North America, and the Monark Group (“Monark”), a full service provider of marketing, IT solutions and outsourced service centers focused on the pharmaceutical industry.
Health Canada introduced a new set of regulations with regards to the production and distribution of medical marijuana in Canada, which became effective on April 1, 2014. Individual municipalities however, still have to give licensed medical marijuana producers permission to operate within its city limits. As a result Delta immediately introduced stringent zoning regulations prohibiting medical marijuana facilities in all zones including agricultural properties. They did however state that applications would be considered on a case-by-case basis.
IHMML had to demonstrate that they had a competent management team, comprehensive security plans and the support of Health Canada. In addition, Delta had an extensive public consultation process to ensure local residents were involved in the decision making. On May 27, 2014, Delta unanimously approved IHMML’s request to operate a 25,000 sq ft facility subject to property taxes being paid at the industrial rate. This rate will apply even in the event that the Provincial Government determines that medical marijuana cultivation is an agricultural use.
The fact that IHMML received conditional approval to operate in Delta demonstrates the caliber of the management team and their mission of creating a world-class medical marijuana company together with Medican. It is also important to note that IHMML is currently the only medical marijuana company that has received permission to operate in Delta. Rick Brar from IHMML stated that the plant would meet stringent Health Canada requirements and described the company as “an open book, full disclosure company.” He added "we fully understand the concerns that the community will have with regards to security, it's only natural. It's for this reason the federal government has created these strict security conditions and pre-conditions for license approval.”
Medican CEO Ken Williams stated, “we are very pleased with this approval in Delta. It reaffirms the wisdom of our choice of Canadian partners. We are continually impressed with the abilities and professionalism of everyone at IHMML.”
About Medican Enterprises Inc.
Medican Enterprises is a bio-pharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market. It’s wholly owned subsidiary Medican Systems Inc. is an industry leader in the design, construction and operation of Medical Marijuana and Cultivation Centers across Canada and the United States. Traded on the OTCBB, Medican drives shareholder value through its scalable business model and commitment to scientific research, operational excellence and regulatory compliance. For more information visit: www.medicaninc.com.
For More Information
Ken Williams, CEO | Medican Enterprises Inc.
Forward-Looking and Cautionary Statements
Certain statements contained herein contain “forward-looking statements” within the meaning of Section 27A of Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medican Enterprises Inc. to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Medican Enterprises Inc. disclaims any obligation to update or to announce publicly the results of any revision of the forward-looking statements contained or incorporated by reference herein to reflect future events or developments. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.